4-Hydroxynonenal - A Toxic Leachable from Clinically Used Administration Materials

Area of Science:

• Pharmaceutical Science
• Analytical Chemistry
• Toxicology

Background:

• Chemicals migrating from processing materials into biopharmaceuticals pose risks.
• Leachables from administration materials are a concern due to lack of clearance.
• Therapeutic proteins are susceptible to chemical modifications, increasing risk.

Purpose of the Study:

• Identify an unknown leachable compound from clinical administration sets.
• Quantify the leachable compound exceeding safety thresholds.

Main Methods:

• Analysis of administration set extracts using a specific assay.
• Identification and quantification of 4-hydroxynonenal (HNE) via LC-MRM analysis after derivatization.

Main Results:

• Potentially genotoxic HNE was detected in all tested administration sets.
• HNE levels in some sets exceeded safety thresholds for genotoxicants.
• Polyvinyl chloride (PVC) was identified as the HNE-releasing polymer.

Conclusions:

• Clinical administration sets require routine leachables studies.
• Manufacturers must address safety concerns regarding chemicals like HNE.
• Focus on administration sets, manufacturing materials, and container closure systems for leachables studies.